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Neisseria gonorrhoeae acquires iron (Fe) efficiently from lactoferrin (LF). A 103-kDa gonococcal outer
membrane LF-binding protein (Lbp) was identified previously. We isolated the structural gene lbpA for Lbp1
by screening a gonococcal library for a clone that could repair an LF2 receptor mutant. An mTnCm3
transposon insertion mutant of lbpA was unable to use LF-bound Fe for growth, unable to bind LF to whole
cells, and unable to express Lbp1. The DNA sequence of lbpA predicted a protein that shared 94% identity with
the meningococcal LF receptor protein, Lbp, and was closely related to Tbp1, one of the transferrin receptor
proteins. Clinical isolates of gonococci are frequently unable to acquire Fe from LF, and LF2 isolates do not
have a functional LF receptor. The wild-type lbpA gene transformed most tested LF2 clinical isolates to LF1,
indicating that lbpA is defective in many clinical isolates.
Lactoferrin (LF) is a high-affinity iron (Fe)-binding glyco-
protein present abundantly in the specific granules of polymor-
phonuclear leukocytes and in mucosal secretions (37, 38). It is
related in structure and function to transferrin (TF), an abun-
dant serum protein (42). An important biological function of
LF is probably the sequestration of free Fe from the environ-
ment of microorganisms, thus inhibiting their growth (54). LF
also serves to reduce levels of free iron and thus to reduce
Haber-Weiss reactions that generate tissue-damaging oxida-
tive radicals (8, 23, 27).
There is evidence that iron acquisition plays an important
role in bacterial virulence (14, 26, 45, 69). Many pathogens
acquire iron by synthesis and secretion of siderophores, com-
pounds that bind Fe with high affinity (7, 43). Neisseria gonor-
rhoeae and the closely related pathogen Neisseria meningitidis
do not appear to synthesize soluble siderophores (41, 44, 60,
70). All tested meningococcal strains utilize LF (40, 48) as well
as TF (4, 41) as an Fe source. Although all gonococcal strains
can utilize TF as an Fe source (41), many cannot use LF-bound
Fe (40, 72). Surveys of clinical isolates showed that 47% of 59
(40) and 70% of 44 (72) clinical isolates were unable to obtain
Fe from LF. The existence of clinical isolates unable to bind
LF has been questioned by Schryvers and Lee (56). Gonococci
can utilize heme, hemin, hemoglobin, and certain siderophores
produced by other bacteria as Fe sources, however (41, 71).
The majority of nonpathogenic Neisseria spp. cannot use either
TF or LF as an Fe source (40, 41). Thus, TF may be an
essential source of Fe in vivo, not only in serum but also on
mucosal surfaces, where TF is exuded during local inflamma-
tion (24). The role of LF-bound Fe utilization in survival on
mucosal surfaces or in other stages of infection is unclear.
The uptake of Fe from TF, in gonococci, involves two re-
ceptor proteins, designated Tbp1 and Tbp2 (100 and 80 to 88
kDa, respectively) (2, 3, 17–19, 34, 56). The genes tbpA and
tbpB encoding these proteins and their roles in TF binding and
Fe acquisition have been described (2, 17–19). The integral
outer membrane protein Tbp1 is required for Fe transport
across the outer membrane and appears to be essential for Fe
acquisition from TF. Tbp2, a surface-exposed lipoprotein, is
not strictly necessary for growth on TF but makes Fe utilization
more efficient (2, 18). A similar TF receptor system consisting
of TBP1 (95 kDa) and TBP2 (69 to 85 kDa) has also been
described in meningococci (36).
Relatively less is known about Fe uptake from LF than from
TF in either gonococci or meningococci. The requirement for
direct contact of cells with LF-bound Fe suggested that a cell
surface receptor for LF was present (39, 57). An LF-specific
gonococcal receptor was identified by Lee and Schryvers by use
of a solid-phase binding assay (35). Affinity purification en-
abled Schryvers and Lee (56), Lee and Bryan (34), and Cor-
nelissen et al. (18) to isolate a protein of 101 or 105 kDa as the
putative LF receptor in the gonococcus. Recently, a meningo-
coccal gene designated iroA encoding a 98-kDa Fe-regulated
outer membrane protein was cloned and sequenced (49). The
iroA gene product was identified subsequently as an LF recep-
tor, and the gene iroA was renamed lbpA (48).
In this study, we sought molecular evidence for the identity
of the gonococcal LF receptor and for the defect in isolates
unable to use LF as a sole Fe source. Results showed that
gonococcal lbpA was very similar to the meningococcal ho-
molog and that lbpA mutations were common in clinical iso-
lates.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and growth conditions. The N. gonor-
rhoeae strains used were wild-type FA19 (39) and MS11 (M. So, Oregon Health
Sciences University, Portland), LF2 clinical isolates F62 (lrf-2), FA1012 (lrf-3),
FA1090 (lrf-8), FA1092 (lrf-5), FA1095 (lrf-6), FA3000 (lrf-4), and FA3002 (lrf-
7), an LF2 ethyl methanesulfonate-induced mutant FA6353 (lrf-1), and a TF2
mutant FA6838 (13, 16, 32). In addition, 34 strains of N. gonorrhoeae isolated
from female prostitutes in Nairobi, Africa, were obtained through the courtesy of
Ian Maclean, University of Manitoba, Manitoba, Winnipeg, Canada. Gonococci
were maintained routinely on GCB agar (Difco Laboratories, Detroit, Mich.)
containing Kellogg supplements I and II (32). Cultures were incubated at 378C
with a 5% CO2 atmosphere. Chemically defined medium (CDM) has been
described previously (13). Free Fe was removed from the medium by adsorption
through Chelex-100 (Bio-Rad, Richmond, Calif.). Determination of the ability of
a mutant to grow on LF was accomplished by streaking colonies from GCB agar
plates onto CDM agar plates containing 2.5 mM either LF or TF, each saturated
to about 20% with Fe, and then incubating the plates for about 40 h. Chelated
CDM broth supplemented with 5 mM partially Fe-saturated LF also was used to
test the ability to use LF as an Fe source. Growth in CDM broth was monitored
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by optical density with a Klett-Summerson colorimeter with a green filter. LF and
TF were purchased from U.S. Biochemical Corporation, Cleveland, Ohio, and
from Sigma Chemical Co., St. Louis, Mo., respectively. Escherichia coli cells were
grown in LB medium supplemented with appropriate antibiotics at 378C.
Membrane preparation. Membranes were prepared in accordance with an
established procedure (18, 70).
SDS-PAGE and Western blot (immunoblot) analysis. Proteins were analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with
7.5% gels (33). Protein bands were visualized by staining with either silver (73)
or Coomassie brilliant blue. For Western blot analysis, proteins from either total
or outer membranes were separated by SDS-PAGE and then transferred elec-
trophoretically to nitrocellulose (67). Immunoblotting was performed as de-
scribed previously (18) with a 1:2,000 dilution of the monoclonal antibody (MAb)
A4FA7, which is specific for meningococcal Lbp (49) and which was kindly
donated by Jan T. Poolman, National Institute of Public Health and Environ-
mental Protection, Bilthoven, The Netherlands.
Whole-cell LF binding assay. Overnight cultures of gonococci in CDM broth
were diluted in fresh CDM medium to an adjusted Klett reading of approxi-
mately 30, added to duplicate cultures containing either no added Fe or 100 mM
ferric citrate, and incubated in a rotary shaker with 5% CO2 for about 5 h until
they reached stationary phase. About 108 CFU were applied to a nitrocellulose
filter by use of a dot blot apparatus (Schleicher & Schuell, Inc., Keene, N.H.).
For dot blot assays of LF receptor function, filters were probed with 10 mg of
partially Fe-saturated human LF per ml, washed three times for 5 min each time
in high-salt buffer (50 mM Tris-HCl [pH 7.5], 500 mM NaCl), and then detected
with horseradish peroxidase (HRP)-conjugated human LF antibody (Accurate
Chemical & Scientific Corp., Westbury, N.Y.). Dot blot assays for TF receptor
activity utilized HRP-conjugated TF and have been described previously (13).
DNA isolation, labeling, colony hybridization, and Southern blotting. Chro-
mosomal DNA was isolated and purified by CsCl gradient ultracentrifugation as
described previously (18). Plasmid DNA was isolated by use of Qiagen (Studio
City, Calif.) columns. DNA was digested with enzymes in accordance with the
manufacturer’s instructions. Plasmid probes were labeled with [a-32P]dCTP
(ICN Radiochemicals) by use of the random prime DNA labeling kit from
Boehringer Mannheim Biochemicals. Oligonucleotides were labeled with
[g-32P]ATP (ICN) by use of polynucleotide kinase by the method of Sambrook
et al. (53). Colony hybridization was carried out as described previously with
32P-labeled DNA (53). For Southern hybridization, DNA was cut with restriction
enzymes, and fragments were separated by electrophoresis on a 0.8% agarose gel
and then transferred to Zetabind nylon membranes (Cuno, Inc., Meriden,
Conn.) as described previously (53). The Southern blot was hybridized and
washed under high-stringency conditions (11).
55Fe uptake. The Fe uptake protocol was described previously (13, 39).
Transformation. E. coli was transformed by the calcium chloride shock pro-
cedure (28). Gonococci were transformed as described previously (10, 13, 61).
LF1 or TF1 transformants were selected on CDM supplemented with either 2.5
mM LF or 2.5 mM TF, each about 20% saturated with Fe.
FA19 chromosomal library construction and screening for clones. A complete
MluI digest of FA19 (LF1) chromosome was fractionated into 2- to 4-, 4- to 6-,
or 6- to 10-kb fragments on an agarose gel. Subsequently, purified DNA from
each size class was tested for transformation of LF2 strain FA6353 to the LF1
phenotype. The results showed that the 4- to 6-kb fragments produced the most
LF1 transformants (data not shown). MluI-digested FA19 DNA fragments of 4
to 6 kb were excised and purified with the Geneclean II kit (Bio 101, Inc., La
Jolla, Calif.) and then ligated to pBluescript derivative pUNCH615 (66) digested
previously with MluI and dephosphorylated with shrimp alkaline phosphatase as
described in the manufacturer’s instructions (U.S. Biochemical). Other libraries
were constructed in pBR322 (Bethesda Research Laboratories [BRL]) with 1.8-
to 2.5-kb and 2.5- to 3.2-kb complete AvaI digests and 2- to 3-kb complete SspI
digests ligated separately into the corresponding sites of linearized pBR322
(BRL) dephosphorylated with shrimp alkaline phosphatase.
The ligation mixtures were used to transform E. coli DH5a MCR (BRL).
Ampicillin-resistant (Apr) transformants were screened for clones containing the
LF receptor gene by a method adapted from Spratt (62). Agar plates containing
about 70 colonies, about half of which were recombinant plasmids, were repli-
cated onto a similar medium and then incubated at 378C for about 12 h. Pools of
colonies were then scraped from the entire plate, and from each pool, plasmid
DNA was isolated by the Qiascreen protocol (Qiagen). The original plates were
stored. DNA from each pool at a concentration of 10 mg/ml was used to trans-
form piliated cells of a gonococcal LF2 strain, FA6353, selecting for growth on
CDM-LF agar. Pools of DNA that produced LF1 transformants were identified,
and progressively smaller pools consisting of fewer colonies were screened in a
similar manner until a single recombinant LF1 clone was identified.
Transposon mutagenesis. The shuttle mutagenesis method developed by Sei-
fert et al. (58) was used to insert mTnCm3 into pUNCH123.
DNA sequencing and sequence analysis. DNA was sequenced directly from
double-stranded plasmid DNA at the Automated DNA Sequencing Facility of
the University of North Carolina—Chapel Hill with an Applied Biosystems
model 373A DNA sequencer by use of the Taq DyeDeoxy Terminator Cycle
Sequencing kit or by the dideoxynucleotide chain termination method (55) with
Sequenase version 2.0 (U.S. Biochemical). The sequence was determined by use
of a set of nested deletions generated by exonuclease III (46), allowing the use
of universal sequence primers as well as designed synthetic primers to complete
desired regions. The DNA sequence was determined for both strands of the lbpA
sequence. Computer analysis of the resulting sequence information was per-
formed with the Genetics Computer Group (University of Wisconsin, Madison)
package (21).
Nucleotide sequence accession number. The nucleotide sequence of lbpA
reported here has been deposited in GenBank under the accession number
U16260.
RESULTS
Isolation of the LF receptor gene. To isolate the gene for the
wild-type LF receptor, we constructed a gonococcal library
enriched for LF1 DNA fragments and screened for the ability
to transform an LF receptor-deficient mutant to LF1 (see
Materials and Methods). Approximately 1,800 E. coli transfor-
mants obtained from the MluI FA19 library in pUNCH615
were divided into 26 pools and screened for their ability to
transform FA6353 (LF2) to LF1. One of these 26 pools
yielded a significant number of LF1 transformants. The
screening procedure was repeated with individual colonies
from the positive pool, and one E. coli isolate whose DNA
transformed FA6353 to LF1 at a frequency of 1024/CFU was
identified. Restriction analysis and hybridization studies
showed that pUNCH122 contained a 2-kb gonococcal insert
(data not shown). The recombinant plasmid pUNCH122 pre-
sumably contained at least a portion of the LF receptor gene.
Further studies described later in this section confirmed this
observation.
The entire LF receptor gene was then cloned (Fig. 1). Oli-
gonucleotide primers close to the ends of the 2.0-kb insert in
pUNCH122 were used as probes for Southern hybridization of
FA19 chromosomal DNA digested with several different re-
striction enzymes. A 17-mer oligonucleotide primer (GBL22)
homologous to the 59 end of pUNCH122 hybridized to a 2.7-kb
AvaI fragment and a 2.5-kb SspI fragment, while the other
probe, a 17-mer oligonucleotide primer (GBL21) homologous
to the 39 end of pUNCH122, hybridized to a 2.3-kb AvaI
fragment on Southern blots (data not shown). Three separate
size-fractionated libraries containing either 2.3- or 2.7-kb AvaI
fragments or 2.5-kb SspI fragments were constructed (see
Materials and Methods). Clones from each library that hy-
bridized with the appropriate oligonucleotide were isolated.
One positive clone from each library, designated pUNCH124,
pUNCH126, and pUNCH127, was selected for further study.
The clones were shown subsequently by sequencing and re-
striction mapping to overlap partially (Fig. 1).
Transposon mutagenesis of the LF receptor gene. To deter-
mine whether the recombinant plasmid pUNCH122 contained
the desired gene, we constructed an mTnCm3 insertion mutant
of pUNCH122 designated pUNCH129 and used pUNCH129
to transform FA19 to Cmr. Transformants were scored for the
LF2 phenotype, and one designated FA6775 was analyzed in
Southern blots for the site of the mTnCm3 insertion. DNA
from FA19 and FA6775 was digested with AvaI and probed
with the 2.7-kb AvaI fragment from pUNCH126. Examination
revealed hybridization to a 4.3-kb AvaI fragment in FA6775
(Fig. 2A, lane 2) but to a 2.7-kb fragment in FA19 (Fig. 2A,
lane 1). The 1.6-kb increase in the size of the AvaI fragment in
FA6775 corresponded to the expected size of the transposon.
Furthermore, hybridization with an mTnCm3-specific probe
(Fig. 2B, lane 2) confirmed that the 4.3-kb AvaI fragment in
FA6775 was due to a double crossover event between the
mTnCm3 mutagenized insert in pUNCH129 and the desired
chromosomal fragment.
LF utilization. Growth of FA6775 was reduced significantly
in CDM supplemented with LF, although growth was normal
VOL. 63, 1995 GONOCOCCAL lbpA GENE 2959
in CDM supplemented with TF (Fig. 3). Growth inhibition in
CDM containing LF was presumably due to sequestering of
free Fe by LF. Fe uptake assays employing either [55Fe]LF or
[55Fe]TF showed that FA6775 was unable to take up [55Fe]LF
but accumulated 55Fe from TF normally (data not shown).
These data showed that FA6775 was incapable of using LF as
an Fe source.
LF binding. An indirect solid-phase dot blot assay employ-
ing HRP-labeled anti-human LF antibodies was used to eval-
uate LF binding. LF1 strain FA19 bound LF well, as expected,
and binding was enhanced when the cells were Fe stressed
(Fig. 4). The transposon mutant FA6775 failed to bind detect-
able LF by this assay (Fig. 4). The failure of FA6775 to bind LF
FIG. 1. Physical map of the N. gonorrhoeae lbpA gene. The restriction map of the cloned FA19 chromosomal fragment(s) is shown at the top. Plasmid designations
are given on the left of the schematic illustration of each insert. GBL21 and GBL22 refer to the oligonucleotides used as probes in isolating the clones pUNCH124
(GBL21) and pUNCH126 and pUNCH127 (GBL22). The length of the cloned insert is shown in kilobases. The heavy and mid-heavy regions of the FA19 chromosome
represent sequenced DNA as shown in Fig. 6. The lbpA ORF is marked with a heavy arrow. Symbol: ç, position of the mTnCm3 insertion in pUNCH129 and strain
FA6775.
FIG. 2. Characterization of the transposon mutant FA6775. Chromosomal
DNAs (5 mg each) were digested with AvaI and subjected to Southern blotting.
The sizes (in kilobases) of the bands are shown on the left. (A) The probe was
a 32P-labeled 2.7-kb AvaI fragment from pUNCH126. (B) The probe was a
mixture of 32P-labeled 1-kb mTnCm3 fragment and 32P-labeled 1.0-kb DNA
ladder (GIBCO-BRL). Lanes: 1, wild-type strain FA19; 2, mutant strain FA6775;
3, 1.0-kb cat DNA (probe); 4, 2.7-kb AvaI insert DNA (probe); 5, 1.0-kb DNA
ladder (with molecular sizes in kilobases on the right).
FIG. 3. Growth of the lbpA mutant FA6775 in CDM in the presence of LF.
Cells were grown initially in CDM overnight and then reinoculated into CDM or
CDM supplemented with LF (5 mM) or TF (5 mM). Symbols: F, FA19 TF; E,
FA19 LF; h, FA6775 with no addition; Ç, FA6775 TF; ■, FA6775 LF. The
results represent a mean of two experiments.
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was independent of Fe starvation, indicating loss of a func-
tional LF receptor. An LF1 transformant designated FA6755
obtained by transforming pUNCH122 DNA into LF2 strain
FA6353 restored the ability to bind LF by this assay, confirm-
ing that pUNCH122 contained DNA essential to expression of
an LF receptor.
SDS-PAGE and Western blot analysis. Outer membranes
prepared from different strains were analyzed by SDS-PAGE
for expression of the Fe-repressible proteins (Fig. 5). Wild-
type strain FA19 (lane 4) and an isogenic LF1 TF2 strain,
FA6338 (lane 2), exhibited a protein band on a silver-stained
SDS-polyacrylamide gel which was slightly larger than 100-kDa
Tbp1 (Fig. 5A, lanes 4 and 6). The LF2 transposon mutant
FA6775 (lane 6) and an LF2 TF2 double mutant, FA6783,
obtained by transforming the TF2 FA6838 strain with LF2
FA6775 DNA (lane 8) lacked the same protein band (Fig. 5A).
This band migrated at the expected position of affinity-purified
Lbp (19, 34, 56) and was seen more readily in mutant FA6338
lacking 100-kDa Tbp1 (lane 2). Immunoblot assays (Fig. 5B)
showed that LF2 mutant strains FA6775 and FA6783 (lanes 6
and 8) failed to react with a MAb specific for meningococcal
Lbp (48, 49). We concluded that the mTnCm3 insertion in
FA6775 blocked the production of Lbp1, a receptor for LF,
presumably by inactivating the lbpA structural gene encoding
Lbp1. We also noted that the Tbp12 mutants showed in-
creased amounts of Lbp1 compared with the Tbp11 strains in
both SDS-polyacrylamide gel andWestern blot assays (Fig. 5A,
lane 2, and Fig. 5B, lane 2). The amount of Lbp1 produced in
the wild-type strain FA19 was significantly less than the
amount of produced Tbp1 (Fig. 5A, lane 4).
Nucleotide sequence analysis. The DNA sequence obtained
from pUNCH122, pUNCH124, pUNCH126, and pUNCH127
(Fig. 1) is presented in Fig. 6. This 3.3-kb region revealed an
open reading frame (ORF) of 2,832 nucleotides starting with
ATG at position 278 and ending with TAA at position 3110.
Putative regulatory sites were identified on the basis of their
similarity to E. coli consensus sequences. An AGGTGG that
resembles the ribosome binding site sequence AGGAGG (59)
was located 5 bases upstream from the putative translational
start site. A sequence GAT ATT GAA AAT GAA GTT G
which matched the consensus E. coli Fur box sequence gaT
aAT gat aAt cAT Tat c (20) at four of seven conserved posi-
tions was located 88 bases upstream of the ribosome binding
site. Unambiguous 210 and 235 sequences (29) were not
clearly identified by inspection of the DNA sequence. The
10-base sequence TTCAGACGGC located 549 bases down-
stream from the translational start site was identical with the
gonococcal DNA uptake sequence (22, 25). Eight bases down-
stream from the termination codon TAA, there was a se-
quence, GCCGTCTGGA, that shares 9 of 10 bases of the
gonococcal DNA uptake sequence (22, 25). Further down-
stream was a string of 7 Ts, suggesting the existence of a
transcription terminator, but no inverted repeat typical of a
rho-independent transcription terminator, was found. We des-
ignated this ORF as lbpA, because it clearly encoded a protein
(Lbp1) involved in the function or expression of the LF recep-
tor.
Translation of the lbpA coding region predicted a protein of
943 amino acids. A typical signal sequence of 24 amino acids
was located at the N terminus. Limited amino-terminal se-
quence of the mature Lbp protein confirmed that the mature
protein started at amino acid 25 of the ORF shown in Fig. 6
(data not shown). The 919-amino-acid mature polypeptide had
a calculated molecular mass of 103 kDa and a pI of 10.16. This
predicted size corresponded well with the observed size of Lbp
of 101 to 105 kDa on SDS-PAGE (18, 35, 56).
A comparison of the nucleotide sequence of gonococcal
lbpA with that of meningococcal lbpA (49) revealed that they
were 94% identical. The upstream sequence of the gonococcal
lbpA lacked the 6-base repeat of either GAT GTT or GAT
GCT that is repeated eight times in the meningococcal lbpA
gene sequence (Fig. 6) (49). The deduced amino acid sequence
of Lbp1 from the gonococcus was 94% identical to that of the
meningococcal Lbp (49) (Fig. 6). Lbp1 also was 46% identical
and 65% similar to Tbp1 (18) of the same gonococcal strain
(data not shown) but only 18% identical and 42% similar to
Tbp2 (2). Alignment of Lbp1 to TonB-dependent outer mem-
FIG. 4. Binding of LF to Fe-sufficient (Fe1) and Fe-stressed (Fe2) whole
cells of the following strains: wild-type FA19; LF1 transformant of FA6353, i.e.,
FA6755; LF2 transposon mutant FA6775; and LF2 ethylmethane sulfonate-
induced mutant FA6353. Concentrations of HRP-conjugated anti-LF antibody
(in nanograms per milliliter) are shown above each column.
FIG. 5. Lbp1 expression by gonococcal and meningococcal strains. (A) Sil-
ver-stained SDS–7.5% polyacrylamide gel; (B) Western blot probed with MAb
A4FA7. Lanes 1 to 8 contain outer membranes from gonococcal strains; lanes 9
and 10 contain total membranes from a meningococcal strain. Lanes 1, 3, 5, 7,
and 9 contain membranes prepared from Fe-sufficient cells; lanes 2, 4, 6, 8, and
10 contain membranes prepared from Fe-stressed cells. Lanes: 1 and 2, LF1 TF2
FA6338; 3 and 4, wild-type FA19; 5 and 6, LF2 TF1 FA6775; 7 and 8, LF2 TF2
FA6783; 9 and 10, wild-type N. meningitidis, strain FAM20 (66).
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FIG. 6. DNA sequence of the N. gonorrhoeae lbpA gene and comparison of the predicted amino acid sequences of N. gonorrhoeae and N. meningitidis (Nm). The
nucleotide sequence of the lbpA region starts from the left-most AvaI site shown in Fig. 1. The putative ribosome binding site (RBS) is marked, the possible Fur binding
site is boxed, and the possible DNA uptake sequences are indicated by horizontal arrows. A typical leader sequence cleavage site (vertical arrow) is proposed. Symbol:
ç, site of the missing 6-bp repeat present in N. meningitidis lbpA. Residues of N. meningitidis that are identical to Lbp1 of N. gonorrhoeae are indicated by dashes. The
asterisk at nucleotide position 1052 indicates the site of 3-bp region (AAA) which is deleted in N. gonorrhoeae but which is present in N. meningitidis. The double asterisk
at nucleotide position 1988 shows the site of a 3-bp region (AAT) which is deleted in N. meningitidis but which is present in N. gonorrhoeae.
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brane receptors (data not shown) showed that Lbp1 was ho-
mologous to the TonB-dependent family of receptors, as was
true for Tbp1 (18) but not for Tbp2 (2). Sequences upstream or
downstream of the lbpA ORF did not show significant amino
acid sequence similarity with other known proteins currently in
GenBank.
Mutation in natural LF2 isolates. Genetic linkage and LF
receptor functional studies reported earlier suggested that the lrf
mutations in LF2 clinical isolates affect LF receptor gene expres-
sion (13). Transforming DNAs from pUNCH126 (containing
all but the 39 end of lbpA) and pUNCH124 (containing the 39
end of the lbpA) (Fig. 1) were tested for their ability to trans-
form seven LF2 clinical isolates to LF1. These strains included
F62, FA1012, FA1092, FA1095, FA3002, and FA6748, which
FIG. 6—Continued.
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were previously shown to contain genetically linked lrf muta-
tions (13), and an additional strain, FA1090 (16). All but
FA1090 and FA3002 were transformed to LF1 by pUNCH126
DNA, but none was transformed to LF1 by pUNCH124 DNA
(data not shown). The presence of restriction and modification
systems active against transforming DNA isolated from a for-
eign host may account for the failure in transformation of
strains FA1090 and FA3002 (64). The lrf-4 mutation in strain
FA3000 could not be transformed to LF1 with FA19 lbpA1
DNA isolated from E. coli cells, but when the FA3000 lrf-4
mutation was introduced (12) into FA19, creating LF2
FA6748 (lrf-4), it was transformed to LF1 by either
pUNCH122 or pUNCH126 DNA at a frequency of about
1024/CFU (data not shown). Similar experiments with the lrf
alleles in FA1090 and FA3002 were not undertaken. Thus, the
lesions in five of seven tested lrf loci were located entirely
within the 2.7-kb AvaI fragment containing lbpA. Since
pUNCH126 included an additional 277 bp upstream of the
lbpAORF (Fig. 6), it is possible that some lrfmutations may be
located just outside lbpA. The location of the five different lrf
lesions in the lbpA locus is consistent with our previous obser-
vation (13) that the lrf loci are closely linked.
To further characterize the nature of the clinical lbpA mu-
tations, we tested the ability of the LF2 strains to revert spon-
taneously to LF1. Strain F62 reverted to LF1 at a frequency of
2 3 1028, while the FA19 derivative strains FA6353 and
FA6748 reverted to LF1 at a frequency of 1 3 1027 and 2 3
1026, respectively. These frequencies suggested that the lbpA
mutations in these strains were point mutations.
To determine whether the lbpA gene was present in natu-
rally occurring LF2 strains, chromosomal DNA from strains
F62, FA1012, FA1090, and FA6748 was digested with AvaI and
tested in a Southern blot with pUNCH126 as the probe. One
hybridizing band was detected in all strains tested, although the
sizes of the band differed (data not shown). This showed that
the lbpA gene was present in clinical strains defective in LF
utilization.
To determine the effect of clinical lbpA mutations on the
expression of the 103-kDa protein, we studied the SDS-PAGE
membrane profile of LF2 strain FA6748 which contains the
lrf-4 allele (Fig. 7). There was no apparent Lbp1 protein in
FA6748. Each of two LF1 strains, FA6854 (lane 5) and
FA6859 (lane 6), obtained by transformation of strain FA6748
with lbpA1 DNA (pUNCH126) and spontaneous reversion of
FA6748 to LF1, respectively, expressed Lbp1. These results
showed that lrf-4 contains a mutation in lbpA, although we did
not attempt to identify the mutation by sequencing lrf-4.
We showed previously that two of the genetically character-
ized lrf mutants lacked LF receptor activity (13). We tested an
additional 10 natural (clinical) LF2 strains, including FA1012,
FA1090, FA1092, FA1095, FA3002, FA6748, and F62, for LF
binding in a solid-phase dot blot assay and obtained similar
results (Fig. 8 and data not shown). Conversely, all tested LF1
strains, including 16 clinical isolates obtained from Ian Mac-
lean, three LF1 transformants, namely, FA6857, FA6854, and
FA6755, obtained by transforming F62 and FA6748 with
pUNCH126 and FA6353 with pUNCH122, and three sponta-
neous revertants, namely, FA6858, FA6859, and FA6860, de-
rived from LF2 strains F62, FA6748, and FA6353, respectively,
exhibited LF receptor activity (Fig. 4 and 8 and data not
shown). This further supported the conclusion that strains un-
able to use LF as an Fe source are uniformly lacking in LF
receptor activity.
Western blots were used to test whether the LF2 isolates
expressed detectable 103-kDa Lbp1 (Fig. 5 and 9). None of 10
tested LF2 clinical isolates expressed detectable levels of
Lbp1, whereas all 18 LF1 strains tested did express Lbp1,
as detected by binding of MAb A4FA7 (Fig. 9 and data
not shown). LF1 transformants or revertants of LF2 strains
(FA6755, FA6854, FA6857, FA6858, FA6859, and FA6860)
were restored in their abilities to bind MAb A4FA7 (Fig. 9 and
data not shown). We concluded that natural LF2 isolates ex-
pressed no Lbp1, bound no detectable LF by solid-phase dot
FIG. 7. Lack of Lbp1 expression due to lrf-4, a natural lbpA mutation. A
silver-stained SDS–7.5% polyacrylamide gel containing outer membranes pre-
pared from Fe-starved cells is shown. The differences in protein profiles (except
for Tbp1 and Lbp1) between lanes 1 to 3 and 4 to 6 are due to the use of two
different batches of outer membrane preparations. Lanes: 1, LF1 FA19; 2, LF2
FA6775; 3, LF2 TF2 FA6783; 4, LF2 FA6748; 5, LF1 FA6854 (a transformant
of FA6748); 6, LF1 FA6859 (a revertant of FA6748).
FIG. 8. Inability of Fe-starved whole cells of LF2 natural gonococcal isolates
to bind LF. Concentrations of HRP-conjugated anti-LF antibody (in nanograms
per milliliter) are shown above each column. Strains are shown on the left.
FIG. 9. Lack of Lbp1 expression by LF2 natural isolates of gonococci. A
Western blot containing total membranes prepared from Fe-starved cells probed
with MAb A4FA7 is shown. Lanes: 1, LF1 strain MS11; 2 through 9, LF2 strains
FA1012, FA1090, FA1092, FA1095, FA3002, FA6353, FA6748, and F62, respec-
tively; 10, LF1 transformant of F62, FA6857.
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blot, and could be repaired by a wild-type lbpA gene or a
closely linked upstream locus.
DISCUSSION
A number of human pathogens can bind LF to their cell
surface, including N. gonorrhoeae (13, 35, 39, 56), N. meningi-
tidis (56, 57), Branhamella catarrhalis (56), Mycoplasma pneu-
moniae (68), Trichomonas vaginalis (47), Treponema pallidum
(1), Treponema denticola (63), Bordetella pertussis (52), and
Aeromonas hydrophila (6). However, the mechanism of Fe up-
take from LF has not been well characterized. A putative
105-kDa receptor for LF utilization was identified in patho-
genic Neisseria spp. by affinity isolation (18, 34, 56). Further
evidence for a specific functional LF receptor was provided by
competitive solid-phase binding assays (35) and isolation of LF
receptor-deficient gonococci (13). We have isolated the gono-
coccal gene lbpA, encoding the 103-kDa gonococcal protein
Lbp1, and have proven that Lbp1 is essential to LF receptor
function and uptake of Fe from LF. While this work was in
progress, an lbpA gene in N. meningitidis was cloned, se-
quenced, and expressed in E. coli, with similar overall conclu-
sions (48, 49).
The DNA sequence of lbpA and the predicted amino acid
sequence of the Lbp1 in the gonococcus and the meningococ-
cus are highly conserved. There are 2,832 bases in the ORFs of
both gonococcal and meningococcal lbpA genes. Both genes
contain relatively well-conserved Fur boxes. Recently, fur ho-
mologs were cloned and characterized in both gonococci (9)
and meningococci (66). Whether the 17-kDa Fur protein is
able to bind to the putative Fur box and regulates expression of
the lbpA gene(s) has yet to be determined. Identification of the
transcriptional start site of lbpA and the regulation of expres-
sion of Lbp1 require further work. The striking 94% identity
between gonococcal and meningococcal Lbp1 suggests that the
two proteins have the same function. A MAb directed against
meningococcal Lbp recognized gonococcal Lbp1 specifically in
all 18 LF1 gonococcal strains tested, suggesting conservation
of that epitope in all gonococci. Curiously, the same MAb does
not bind to all meningococcal Lbp1s (49). The striking conser-
vation of the predicted proteins in gonococci and meningo-
cocci (94% identity) strongly suggests that Lbp1 does not un-
dergo much antigenic variation in vivo, perhaps indicating that
Lbp1 is masked or not highly surface exposed.
Lbp1 shares features with the functionally related gonococ-
cal TF receptor protein Tbp1 (18). Each protein has a 24-
amino-acid signal sequence, similar patterns of alternating hy-
drophobic and hydrophilic residues in the last 10 amino acids,
a C-terminal phenylalanine (65), and extensive homology with
the TonB-dependent receptors (31, 51), and each is highly
basic. These characteristics are consistent with the possibility
that Lbp1 is a TonB-dependent outer membrane receptor pro-
tein. The strong similarity between the LF receptor protein
Lbp1 and the TF receptor protein Tbp1 suggests that the
binding of LF to gonococcal cells might be similar to TF
binding. The TF receptor is composed of two proteins, Tbp1
and Tbp2, that arise from transcription of a single tbpB-tbpA
operon (2). A tbpB probe hybridized only to the expected tbpB
restriction fragments in low-stringency Southern blots (data
not shown), suggesting that if there is an lbpB gene analogous
to tbpB, the two genes are not highly conserved. The very sticky
nature of LF has made it technically difficult to perform LF
Western blots analogous to the TF Western blots that identi-
fied Tbp2 (2). Further experiments are required to address the
possibility that there could be a second LF-binding protein
analogous to Tbp2 (2).
The mechanisms of Fe removal from LF after binding of LF
to the receptor and the subsequent transport of Fe across the
cell membrane are unknown. Removal of Fe from the Fe-
binding proteins LF and TF might involve a common protein.
The presence of such a protein is suggested by a tlu mutation
that does not interfere with LF or TF receptor function but
that prevents Fe uptake from either LF or TF (13). Further
characterization of the tlu locus may elucidate the mechanism
of Fe removal from receptor proteins.
Using genetic studies, we showed previously that TF recep-
tor mutations designated trf were clustered (13). Subsequently,
we showed that all known trfmutations lay within a 2.8-kb tbpA
structural gene (18). LF receptor (lrf) mutants are similar in
that most of the identified lrf mutations are now known to be
located in or immediately adjacent to lbpA. Naturally occurring
trf mutations have not been described, but most of the studied
lrf mutations were identified in clinical isolates. This clearly
suggests that Lbp1 is not essential for gonococcal survival on
mucosal surfaces.
Mickelsen et al. concluded that many clinical isolates of
gonococci were unable to utilize LF-bound Fe on the basis of
their inability to support growth in the presence of LF-bound
Fe and their failure to take up radioactive Fe from LF (40).
This finding was challenged by Schryvers and Lee, who found
that all gonococcal isolates exhibited LF receptor activity by a
solid-phase binding assay (56). In this study, we confirm that
many gonococci are LF receptor deficient and show that they
cannot use LF as a sole source of Fe because they are mutant
in or near lbpA and fail to express Lbp1. Other unpublished
surveys showing that at least 30% of over 800 tested gonococ-
cal isolates do not grow on CDM supplemented with LF have
been conducted (38a, 72). Therefore, it is unlikely that the
discrepancies in our work and that of Schryvers and Lee (56)
are due to the use of different collections of strains. We con-
clude that many gonococci do not express a functional LF
receptor. Of course, many other mucosal pathogens, including
Haemophilus influenzae (30, 50) as well as other bacteria that
colonize mucosal surfaces (26, 45), are not able to use LF as an
Fe source, suggesting that other sources are available in vivo.
Some serum TF probably exudes onto inflamed surfaces (24),
which could supply the Fe needs of all gonococci. The advan-
tage of expressing a functional LF receptor remains enigmatic.
LF is bactericidal to many microorganisms (5, 15, 54). The
mucosal surface and polymorphonuclear leukocytes are rich in
LF (37, 38). It is possible, but untested, that an LF receptor
might protect against binding of LF to another site, thereby
avoiding the bactericidal effects of LF. It is also possible that a
functional LF receptor aids infection in vivo by providing an
additional but nonessential means to scavenge Fe from the
environment. Further work is required to understand the func-
tional implications of genetic variability in the LF receptor.
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